Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14974219 | 0.83 | ALDH1A1 (0.59) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14973719 | 0.82 | GAA (0.43) | GAAALDH1A1LMNAKDM4EMAPT | |
| Hydrochloric Acid SCHEMBL14974213 | 0.82 | ALDH1A1 (0.58) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14715160 | 0.82 | SMN1; SMN2 (0.39) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14973631 | 0.82 | L3MBTL1 (0.53) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14715230 | 0.79 | ALDH1A1 (0.44) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14973979 | 0.77 | ALDH1A1 (0.38) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14715164 | 0.73 | HSD17B10 (0.40) | GAAALDH1A1LMNASMN1; SMN2POLB | |
| SCHEMBL14714770 | 0.73 | ALDH1A1 (0.50) | GAAALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL14715114 | 0.73 | ALDH1A1 (0.44) | GAAALDH1A1LMNAKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130136794-A1 | HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | PEKING UNIVERSITY (CN) | 2013-05-30 | — | — | US | claimed |
| US-20130136794-A1 | HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | PEKING UNIVERSITY (CN) | 2013-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130136794-A1 | HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | LTK, ERBB2, ABL1 | GAA 1564/4885ALDH1A1 2942/4885LMNA 3892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.